Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.

ALXN

Alexion Pharmaceuticals (ALXN)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ALXN
DataOraFonteTitoloSimboloCompagnia
28/07/202310:54KR Market News알렉시온, 화이자 유전자 치료제를 10억 달러 인수 합의NASDAQ:ALXNAlexion Pharmaceuticals Inc
28/07/202310:23KR Market News아스트라제네카, 항암제 수요로 2분기 결과 예상치 상회NASDAQ:ALXNAlexion Pharmaceuticals Inc
26/07/202112:02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ALXNAlexion Pharmaceuticals Inc
23/07/202122:55Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
22/07/202115:09Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ALXNAlexion Pharmaceuticals Inc
22/07/202112:27Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ALXNAlexion Pharmaceuticals Inc
21/07/202115:12Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:ALXNAlexion Pharmaceuticals Inc
16/07/202101:01PR Newswire (US)Moderna Set to Join S&P 500NASDAQ:ALXNAlexion Pharmaceuticals Inc
15/07/202122:05Business WireAlexion Announces Positive Topline Results from Phase 3 Study of ULTOMIRIS® (ravulizumab-cwvz) in Adults with Generalized My...NASDAQ:ALXNAlexion Pharmaceuticals Inc
15/07/202102:00GlobeNewswire Inc.Honeywell International Inc. to Join the NASDAQ-100 Index Beginning July 21, 2021NASDAQ:ALXNAlexion Pharmaceuticals Inc
14/07/202118:13Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:ALXNAlexion Pharmaceuticals Inc
14/07/202111:11Dow Jones NewsAstraZeneca Says $39 Billion Alexion Deal Set for Completion After UK Clearance -- UpdateNASDAQ:ALXNAlexion Pharmaceuticals Inc
14/07/202108:30Dow Jones NewsUK Regulator Clears AstraZeneca's Alexion DealNASDAQ:ALXNAlexion Pharmaceuticals Inc
11/06/202109:01Business WireCaelum & Alexion Present Additional Phase 2 Data Reinforcing Safety & Tolerability of CAEL-101 in AL Amyloidosis at the Europ...NASDAQ:ALXNAlexion Pharmaceuticals Inc
07/06/202119:55Business Wire Alexion Announces FDA Approval of ULTOMIRIS® (ravulizumab-cwvz) for Children & Adolescents with Paroxysmal Nocturnal Hemog...NASDAQ:ALXNAlexion Pharmaceuticals Inc
04/06/202122:22Dow Jones NewsAstraZeneca Taps Alexion Executive for CFO Job -- UpdateNASDAQ:ALXNAlexion Pharmaceuticals Inc
04/06/202108:40Dow Jones NewsAstraZeneca Names Aradhana Sarin as Next CFONASDAQ:ALXNAlexion Pharmaceuticals Inc
27/05/202108:43Dow Jones NewsAstraZeneca Prices EUR800 Million Bond OfferingNASDAQ:ALXNAlexion Pharmaceuticals Inc
26/05/202108:43Dow Jones NewsAstraZeneca Prices $7 Billion Bond Offering to Partly Fund Alexion AcquisitionNASDAQ:ALXNAlexion Pharmaceuticals Inc
25/05/202108:41Dow Jones NewsUK Watchdog Starts Investigation Into AstraZeneca's Acquisition of AlexionNASDAQ:ALXNAlexion Pharmaceuticals Inc
13/05/202114:06Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:ALXNAlexion Pharmaceuticals Inc
12/05/202122:14Business WireCaelum and Alexion Announce Upcoming CAEL-101 Data Presentations at the European Hematology Association Congress 2021NASDAQ:ALXNAlexion Pharmaceuticals Inc
12/05/202122:01Business WireAlexion Announces Upcoming Data Presentations at the 26th European Hematology Association Virtual CongressNASDAQ:ALXNAlexion Pharmaceuticals Inc
12/05/202110:52TipRanksAlexion Investors Approve Acquisition By AstraZenecaNASDAQ:ALXNAlexion Pharmaceuticals Inc
11/05/202122:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ALXNAlexion Pharmaceuticals Inc
11/05/202115:28Business WireAlexion Shareholders Approve Acquisition by AstraZenecaNASDAQ:ALXNAlexion Pharmaceuticals Inc
30/04/202114:27Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ALXNAlexion Pharmaceuticals Inc
30/04/202114:00Business WireAlexion Reports First Quarter 2021 ResultsNASDAQ:ALXNAlexion Pharmaceuticals Inc
28/04/202123:00Business WireUPDATED Alexion to Report First Quarter 2021 Results on Friday, April 30, 2021NASDAQ:ALXNAlexion Pharmaceuticals Inc
20/04/202114:00Business WireAlexion to Report First Quarter 2021 Results on Monday, May 3, 2021NASDAQ:ALXNAlexion Pharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ALXN
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network